Immediate Impact
48 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
2024 Standout
Works of Thomas Peppard being referenced
Study of Aldosterone Synthase Inhibition as an Add‐On Therapy in Resistant Hypertension
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Thomas Peppard | 70 | 72 | 122 | 80 | 75 | 8 | 270 | |
| Cristóbal Fuentes | 99 | 20 | 134 | 31 | 76 | 12 | 320 | |
| Timothy Doulton | 153 | 58 | 79 | 34 | 27 | 13 | 300 | |
| Carole Deprele | 55 | 82 | 35 | 38 | 52 | 4 | 276 | |
| Guillaume Dautin | 57 | 86 | 89 | 24 | 76 | 8 | 335 | |
| Shang-Jyh Hwang | 32 | 67 | 39 | 49 | 66 | 7 | 273 | |
| Andrés Castillo | 69 | 47 | 47 | 117 | 25 | 11 | 307 | |
| Kai Yan Mak | 87 | 146 | 94 | 35 | 43 | 9 | 328 | |
| Guadalupe Suárez | 19 | 41 | 84 | 44 | 44 | 9 | 266 | |
| Jianbo Xu | 94 | 38 | 110 | 51 | 87 | 17 | 268 | |
| Anna Carolina Galvão Ferreira | 70 | 29 | 131 | 50 | 41 | 11 | 315 |
All Works
Login with ORCID to disown or claim papers
Loading papers...